Cargando…

Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery

PURPOSE: Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardi...

Descripción completa

Detalles Bibliográficos
Autores principales: De Witt Hamer, Philip C., Ho, Vincent K. Y., Zwinderman, Aeilko H., Ackermans, Linda, Ardon, Hilko, Boomstra, Sytske, Bouwknegt, Wim, van den Brink, Wimar A., Dirven, Clemens M., van der Gaag, Niels A., van der Veer, Olivier, Idema, Albert J. S., Kloet, Alfred, Koopmans, Jan, ter Laan, Mark, Verstegen, Marco J. T., Wagemakers, Michiel, Robe, Pierre A. J. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700042/
https://www.ncbi.nlm.nih.gov/pubmed/31236819
http://dx.doi.org/10.1007/s11060-019-03229-5
_version_ 1783444782553497600
author De Witt Hamer, Philip C.
Ho, Vincent K. Y.
Zwinderman, Aeilko H.
Ackermans, Linda
Ardon, Hilko
Boomstra, Sytske
Bouwknegt, Wim
van den Brink, Wimar A.
Dirven, Clemens M.
van der Gaag, Niels A.
van der Veer, Olivier
Idema, Albert J. S.
Kloet, Alfred
Koopmans, Jan
ter Laan, Mark
Verstegen, Marco J. T.
Wagemakers, Michiel
Robe, Pierre A. J. T.
author_facet De Witt Hamer, Philip C.
Ho, Vincent K. Y.
Zwinderman, Aeilko H.
Ackermans, Linda
Ardon, Hilko
Boomstra, Sytske
Bouwknegt, Wim
van den Brink, Wimar A.
Dirven, Clemens M.
van der Gaag, Niels A.
van der Veer, Olivier
Idema, Albert J. S.
Kloet, Alfred
Koopmans, Jan
ter Laan, Mark
Verstegen, Marco J. T.
Wagemakers, Michiel
Robe, Pierre A. J. T.
author_sort De Witt Hamer, Philip C.
collection PubMed
description PURPOSE: Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardized survival outcome after glioblastoma surgery and to explore the association between survival and hospital characteristics in conjunction with patient-related risk factors. METHODS: Data of 2,409 adults with first-time glioblastoma surgery at 14 hospitals were obtained from a comprehensive, prospective population-based Quality Registry Neuro Surgery in The Netherlands between 2011 and 2014. We compared the observed survival with patient-specific risk-standardized expected early (30-day) mortality and late (2-year) survival, based on age, performance, and treatment year. We analyzed funnel plots, logistic regression and proportional hazards models. RESULTS: Overall 30-day mortality was 5.2% and overall 2-year survival was 13.5%. Median survival varied between 4.8 and 14.9 months among hospitals, and biopsy percentages ranged between 16 and 73%. One hospital had lower than expected early mortality, and four hospitals had lower than expected late survival. Higher case volume was related with lower early mortality (P = 0.031). Patient-related risk factors (lower age; better performance; more recent years of treatment) were significantly associated with longer overall survival. Of the hospital characteristics, longer overall survival was associated with lower biopsy percentage (HR 2.09, 1.34–3.26, P = 0.001), and not with academic setting, nor with case volume. CONCLUSIONS: Hospitals vary more in late survival than early mortality after glioblastoma surgery. Widely varying biopsy percentages indicate treatment variation. Patient-related factors have a stronger association with overall survival than hospital-related factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11060-019-03229-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6700042
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-67000422019-08-29 Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery De Witt Hamer, Philip C. Ho, Vincent K. Y. Zwinderman, Aeilko H. Ackermans, Linda Ardon, Hilko Boomstra, Sytske Bouwknegt, Wim van den Brink, Wimar A. Dirven, Clemens M. van der Gaag, Niels A. van der Veer, Olivier Idema, Albert J. S. Kloet, Alfred Koopmans, Jan ter Laan, Mark Verstegen, Marco J. T. Wagemakers, Michiel Robe, Pierre A. J. T. J Neurooncol Clinical Study PURPOSE: Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardized survival outcome after glioblastoma surgery and to explore the association between survival and hospital characteristics in conjunction with patient-related risk factors. METHODS: Data of 2,409 adults with first-time glioblastoma surgery at 14 hospitals were obtained from a comprehensive, prospective population-based Quality Registry Neuro Surgery in The Netherlands between 2011 and 2014. We compared the observed survival with patient-specific risk-standardized expected early (30-day) mortality and late (2-year) survival, based on age, performance, and treatment year. We analyzed funnel plots, logistic regression and proportional hazards models. RESULTS: Overall 30-day mortality was 5.2% and overall 2-year survival was 13.5%. Median survival varied between 4.8 and 14.9 months among hospitals, and biopsy percentages ranged between 16 and 73%. One hospital had lower than expected early mortality, and four hospitals had lower than expected late survival. Higher case volume was related with lower early mortality (P = 0.031). Patient-related risk factors (lower age; better performance; more recent years of treatment) were significantly associated with longer overall survival. Of the hospital characteristics, longer overall survival was associated with lower biopsy percentage (HR 2.09, 1.34–3.26, P = 0.001), and not with academic setting, nor with case volume. CONCLUSIONS: Hospitals vary more in late survival than early mortality after glioblastoma surgery. Widely varying biopsy percentages indicate treatment variation. Patient-related factors have a stronger association with overall survival than hospital-related factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11060-019-03229-5) contains supplementary material, which is available to authorized users. Springer US 2019-06-24 2019 /pmc/articles/PMC6700042/ /pubmed/31236819 http://dx.doi.org/10.1007/s11060-019-03229-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Study
De Witt Hamer, Philip C.
Ho, Vincent K. Y.
Zwinderman, Aeilko H.
Ackermans, Linda
Ardon, Hilko
Boomstra, Sytske
Bouwknegt, Wim
van den Brink, Wimar A.
Dirven, Clemens M.
van der Gaag, Niels A.
van der Veer, Olivier
Idema, Albert J. S.
Kloet, Alfred
Koopmans, Jan
ter Laan, Mark
Verstegen, Marco J. T.
Wagemakers, Michiel
Robe, Pierre A. J. T.
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
title Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
title_full Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
title_fullStr Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
title_full_unstemmed Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
title_short Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
title_sort between-hospital variation in mortality and survival after glioblastoma surgery in the dutch quality registry for neuro surgery
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700042/
https://www.ncbi.nlm.nih.gov/pubmed/31236819
http://dx.doi.org/10.1007/s11060-019-03229-5
work_keys_str_mv AT dewitthamerphilipc betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT hovincentky betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT zwindermanaeilkoh betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT ackermanslinda betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT ardonhilko betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT boomstrasytske betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT bouwknegtwim betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT vandenbrinkwimara betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT dirvenclemensm betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT vandergaagnielsa betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT vanderveerolivier betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT idemaalbertjs betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT kloetalfred betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT koopmansjan betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT terlaanmark betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT verstegenmarcojt betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT wagemakersmichiel betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT robepierreajt betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery
AT betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery